Hungarians conduct COVID drug experiments in space (article in Hungarian)

The COVID-19 epidemic posed new and pressing challenges for pharmaceutical researchers. Gilead Sciences’ Veklury was the first drug to treat COVID-19 infection that was provisionally approved in more than 50 countries. It is also the first product to receive a full, and therefore not temporary, and emergency license from the U.S. Food and Drug Administration (FDA) in October 2020…

….

Hungarian InnoStudio Zrt., Which is the leading international player in space chemistry as a new industry and CycloLab Kft., The primary European manufacturer of the excipient of remdesivir, is the first in the world to investigate the possible effects of microgravity during the remdesivir-SBECD interaction.

Read the full Hungarian article on 24.hu

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Latest News & Events

Invited talk at the HU-ISR Joint Virtual Space Workshop

Invited talk at the HU-ISR Joint Virtual Space Workshop

Beyond Borders – Joint Virtual Space Workshop between the MFA Department for Space Activities and the Embassy of the State of Israel The Institute for Foreign Affairs and Trade,along with the Ministry of Foreign Affairs and Tradeand the Embassy of the State of...

First experiments in space for COVID-19 drug research

First experiments in space for COVID-19 drug research

The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by Gilead Sciences Inc., has already been approved or authorized for temporary use in approximately 50 countries...

Latest Articles